Inclusion and exclusion criteria for enrolment in the 2-year AMBRA-study
| Inclusion criteria | Exclusion criteria |
|---|---|
| ▸ Age>18 ▸ DAS28-CRP<3.2 ▸ HAQ<2.5 ▸ Disease duration>1.5 years ▸ No increase in DMARD or steroids for the past 3 months ▸ Oral and written consent to participate | ▸ Biological or Myocrisine treatment ▸ Comorbidities with life expectancy<5 years ▸ Systemic manifestations apart from rheumatic nodules ▸ Pregnancy ▸ Simultaneous participation in other studies ▸ Lack of cognitive ability or problems related to the Danish language and thus unable to participate in group sessions, complete questionnaires and be contacted by phone |
AMBRA, AMBulant behandling af Reumatoid Artrit/Outpatient; DAS28-CRP, composite disease activity score based on a 28 joint count of tender and swollen joints, c-reactive protein and patient global assessment score; DMARD, disease-modifying antirheumatic drugs; HAQ, Health Assessment Questionnaire.